US · Healthcare

Dyadic International Inc (DYAI)

Biotechnology

Dyadic International Inc (DYAI) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for DYAI

P/E ratio

18.00

Dyadic International Inc (DYAI) — FAQ

What is DYAI's P/E ratio?

The price-to-earnings (P/E) ratio for Dyadic International Inc (DYAI) is 18.00 (data as of 2026-03-24).

Does Dyadic International Inc pay a dividend?

Dividend yield is not available in the current snapshot for Dyadic International Inc (DYAI). Check the MyAverix Finance app for the latest dividend data.

What sector is Dyadic International Inc in?

Dyadic International Inc (DYAI) is classified in the Healthcare sector (Biotechnology industry).

What exchange is DYAI listed on?

DYAI is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)